Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: September 2008
-
By Kevin E. Noonan — The New York Times seems to have an unending supply of pundits willing to support its anti-patent agenda, as has been noted on this blog before (see below). The latest example is an article in this Saturday’s paper, entitled "When Academia Puts Profit Ahead of Wonder," by Janet…
-
September 11, 2008 – Developments in Pharmaceutical and Biotech Patent Law (Practising Law Institute) – New York, NY September 11-12, 2008 – Current Issues in Complex IP Licensing (Law Seminars International) – Philadelphia, PA September 15-16, 2008 – Biotech Patents*** (American Conference Institute) September 16, 2008 – The Legacy of Judge Howard T. Markey*** (The…
-
American Conference Institute (ACI) will be holding its Pharmaceutical and Biotech Patent Opinion Writing conference on November 17-18, 2008 in Boston, MA. The conference, which will be repeated on December 8-9, 2008 in Atlanta, GA and on January 12-13, 2009 in San Diego, CA, will provide hands-on training with respect to: • Writing non-infringement and…
-
The Center for Intellectual Property Law at the John Marshall Law School in Chicago, IL will be presenting a one-day conference entitled: "The Legacy of Judge Howard T. Markey" on September 16, 2008. The conference will celebrate the legacy of Judge Markey, who served on the bench from 1972 to 1991, played a historic role…
-
By Donald Zuhn — Isis Pharmaceuticals, Inc. announced today that the U.S. Patent and Trademark Office has issued notices of allowance for U.S. Application Nos. 10/281,312 and 10/281,297. According to the company’s press release, the two allowances "significantly expand" the scope of Isis’ Crooke patent estate — a family of patents based on…
-
By Kevin E. Noonan — Earlier today, Patent Docs participated in a conference call with Jim Greenwood, the President and CEO of the Biotechnology Industry Organization (BIO) and Joshua Boger, Ph.D., Chairman of BIO’s Board and President and CEO of Vertex Pharmaceuticals Inc. Mr. Greenwood, who represented Pennsylvania’s Eighth District in the U.S.…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office announced that the Patent Prosecution Highway (PPH) pilot program with the United Kingdom Intellectual Property Office (UKIPO), which was initiated on September 4, 2007, would be extended until further notice. The USPTO and UKIPO will continue to periodically monitor the program…
-
By Sherri Oslick — Patent Docs readers anxiously awaiting GSK/Tafas’ brief will have to wait a little longer. On August 14, the parties jointly moved to modify the briefing schedule; the motion was granted today (September 2). The schedule as it now stands is as follows: • September 24, 2008: Appellees’ briefs due…
-
By Kevin E. Noonan — Monsanto has been very successful in defending its Roundup Ready® franchise of genetically-engineered crop varieties. Monsanto sells patented seeds to a variety of crop plants, including soybeans, that are resistant to Monsanto’s Roundup® glyphosphate herbicide. These sales are conditioned by an agreement, termed the "Technology Agreement" that requires…
-
By Donald Zuhn — In an e-Commerce e-Alert distributed on Friday, the U.S. Patent and Trademark Office announced that it was seeking up to 1,000 registered practitioners to help with a pilot test of the Office’s new online Continuing Education for Practitioners (CEP) system. According to the Office’s call for volunteers, the goal…
Patent Docs 